SVB Leerink Maintains Market Perform on Elevance Health, Lowers Price Target to $490
SVB Leerink analyst Whit Mayo maintains Elevance Health (NYSE:ELV) with a Market Perform and lowers the price target from $555 to $490.
Elevance Health Raises Annual Profit Guidance
Elevance Health Inc (NYSE:ELV), previously known as Anthem Inc, has reported Q2 FY22 adjusted EPS of $8.04, up 14.4% Y/Y, beating…
Earnings Scheduled For July 20, 2022
Companies Reporting Before The Bell
• Wipro (NYSE:WIT) is projected to report quarterly earnings at $0.08 per share on revenue of $2.80 billion.
A Preview Of Elevance Health’s Earnings
Elevance Health (NYSE:ELV) is set to give its latest quarterly earnings report on Wednesday, 2022-07-20. Here's what investors need to know before the announcement.
Analysts estimate that Elevance Health will report an earnings per share (EPS) of $7.74.
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today
Elevance Health (NYSE:ELV) has outperformed the market over the past 5 years by 11.14% on an annualized basis producing an average annual return of 20.27%. Currently, Elevance Health has a market capitalization of $114.93 billion.